 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 October 2000 | Volume 133 Issue 8 | Pages 592-599
Background: Hepatitis C virus (HCV) infection may contribute to the development of diabetes mellitus. This relationship has not been investigated at the population level, and its biological mechanism remains unknown.
Objective: To examine the prevalence of type 2 diabetes among persons with HCV infection in a representative sample of the general adult population of the United States.
Design: Cross-sectional national survey.
Setting: The Third National Health and Nutrition Examination Survey, 1988–1994.
Participants: 9841 persons older than 20 years of age for whom data on HCV infection and diabetes were complete.
Measurements: The presence of diabetes was ascertained by using American Diabetes Association guidelines based on fasting plasma glucose measurement and medication history. Presence of HCV infection was assessed by testing for serum HCV-specific antibodies (anti-HCV).
Results: Of the 9841 persons evaluated, 8.4% had type 2 diabetes and 2.1% were anti-HCV positive. Type 2 diabetes occurred more often in persons who were older, were nonwhite, had a high body mass index, and had low socioeconomic status. Type 2 diabetes was less common in persons who acknowledged previous illicit drug use. After adjustment for these factors, persons 40 years of age or older with HCV infection were more than three times more likely than those without HCV infection to have type 2 diabetes (adjusted odds ratio, 3.77 [95% CI, 1.80 to 7.87]). None of the 19 persons with type 1 diabetes were anti-HCV positive.
Conclusion: In the United States, type 2 diabetes occurs more often in persons with HCV infection who are older than 40 years of age.
Author and Article Information
From Johns Hopkins University School of Hygiene and Public Health and Johns Hopkins University School of Medicine, Baltimore, Maryland.
Grant Support: In part by Public Health Service grants 1 R01 DA10627 and 1 F31 DA06007 from the National Institute on Drug Abuse, National Institutes of Health.
Requests for Single Reprints: David L. Thomas, MD, MPH, Johns Hopkins Medical Institutions, 1147 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205.
Current Author Addresses: Ms. Mehta: Johns Hopkins Medical Institutions, 615 North Wolfe Street, Box 82, Baltimore, MD 21205.
Dr. Brancati: Johns Hopkins Medical Institutions, 2024 East Monument Street, Suite 2-600, Baltimore, MD 21205.
Dr. Sulkowski: Johns Hopkins Medical Institutions, 1830 East Monument Street, Suite 450-C, Baltimore, MD 21205.
Dr. Strathdee: Johns Hopkins Medical Institutions, 615 North Wolfe Street, E 6010, Baltimore, MD 21205.
Dr. Szklo: Johns Hopkins Medical Institutions, 615 North Wolfe Street, 6009, Baltimore, MD 21205.
Dr. Thomas: 1147 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205.
Author Contributions: Conception and design: S.H. Mehta, F.L. Brancati, M.S. Sulkowski, D.L. Thomas.
Analysis and interpretation of the data: S.H. Mehta, F.L. Brancati, M.S. Sulkowski, M. Szklo, D.L. Thomas.
Drafting of the article: S.H. Mehta, D.L. Thomas.
Critical revision of the article for important intellectual content: S.H. Mehta, F.L. Brancati, M.S. Sulkowski, S.A. Strathdee, M. Szklo, D.L. Thomas.
Final approval of the article: S.H. Mehta, M.S. Sulkowski, S.A. Strathdee, M. Szklo, D.L. Thomas.
Statistical expertise: S.H. Mehta, M. Szklo.
Obtaining of funding: S.H. Mehta.
Administrative, technical, or logistic support: S.H. Mehta, S.A. Strathdee. ARTICLE
Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  D Marzouk, J Sass, I Bakr, M El Hosseiny, M Abdel-Hamid, C Rekacewicz, N Chaturvedi, M K Mohamed, and A Fontanet Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt Gut, August 1, 2007; 56(8): 1105 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study Am. J. Epidemiol., July 15, 2007; 166(2): 196 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kamar, C. Mariat, M. Delahousse, J. Dantal, A. Al Najjar, E. Cassuto, N. Lefrancois, O. Cointault, G. Touchard, F. Villemain, et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1986 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Swaminathan, V. A. Fonseca, M. G. Alam, and S. V. Shah The Role of Iron in Diabetes and Its Complications Diabetes Care, July 1, 2007; 30(7): 1926 - 1933. [Full Text] [PDF]
|
|
|
|
|
|
K. G. Tolman, V. Fonseca, A. Dalpiaz, and M. H. Tan Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease Diabetes Care, March 1, 2007; 30(3): 734 - 743. [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Crutchlow and R. D. Bloom Transplant-Associated Hyperglycemia: A New Look at an Old Problem Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 343 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Simo, A. Lecube, J. Genesca, J. I. Esteban, and C. Hernandez Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection. Diabetes Care, November 1, 2006; 29(11): 2462 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-S. KWEON, M.-H. SHIN, H.-J. SONG, D.-Y. JEON, and J.-S. CHOI SEROPREVALENCE AND RISK FACTORS FOR HEPATITIS C VIRUS INFECTION AMONG FEMALE COMMERCIAL SEX WORKERS IN SOUTH KOREA WHO ARE NOT INTRAVENOUS DRUG USERS Am J Trop Med Hyg, June 1, 2006; 74(6): 1117 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, and R. Simo Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients: A case-control study Diabetes Care, May 1, 2006; 29(5): 1096 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, and R. Simo Glucose Abnormalities in Patients with Hepatitis C Virus Infection: Epidemiology and pathogenesis Diabetes Care, May 1, 2006; 29(5): 1140 - 1149. [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Tsui, E. Vittinghoff, M. G. Shlipak, and A. M. O'Hare Relationship between Hepatitis C and Chronic Kidney Disease: Results from the Third National Health and Nutrition Examination Survey J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1168 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Aspects of type 2 diabetes and related insulin-resistant States. Diabetes Care, March 1, 2006; 29(3): 732 - 740. [Full Text] [PDF]
|
|
|
|
|
|
A. Antonelli, C. Ferri, P. Fallahi, A. Pampana, S. M. Ferrari, F. Goglia, and E. Ferrannini Hepatitis C Virus Infection: Evidence for an association with type 2 diabetes Diabetes Care, October 1, 2005; 28(10): 2548 - 2550. [Full Text] [PDF]
|
|
|
|
|
|
L Fartoux, A Poujol-Robert, J Guechot, D Wendum, R Poupon, and L Serfaty Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C Gut, July 1, 2005; 54(7): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Knobler and A. Schattner TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad QJM, January 1, 2005; 98(1): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Transplantation and Islet Topics Diabetes Care, January 1, 2005; 28(1): 213 - 219. [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, J. I. Esteban, R. Jardi, L. Garcia, and R. Simo Diabetes Is the Main Factor Accounting for the High Ferritin Levels Detected in Chronic Hepatitis C Virus Infection Diabetes Care, November 1, 2004; 27(11): 2669 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kawaguchi, T. Yoshida, M. Harada, T. Hisamoto, Y. Nagao, T. Ide, E. Taniguchi, H. Kumemura, S. Hanada, M. Maeyama, et al. Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 Am. J. Pathol., November 1, 2004; 165(5): 1499 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lecube, C. Hernandez, J. Genesca, J. I. Esteban, R. Jardi, and R. Simo High Prevalence of Glucose Abnormalities in Patients With Hepatitis C Virus Infection: A multivariate analysis considering the liver injury Diabetes Care, May 1, 2004; 27(5): 1171 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Antonelli, C. Ferri, P. Fallahi, M. Sebastiani, C. Nesti, L. Barani, R. Barale, and E. Ferrannini Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients Rheumatology, February 1, 2004; 43(2): 238 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou Community-based Study of Hepatitis C Virus Infection and Type 2 Diabetes: An Association Affected by Age and Hepatitis Severity Status Am. J. Epidemiol., December 15, 2003; 158(12): 1154 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schattner and H. Knobler Clinical Aspects of Chronic Hepatitis C Infection JAMA, September 17, 2003; 290(11): 1453 - 1453. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Flamm Clinical Aspects of Chronic Hepatitis C Infection--Reply JAMA, September 17, 2003; 290(11): 1453 - 1454. [Full Text] [PDF]
|
|
|
|
|
|
V Ratziu, M Saboury, and T Poynard Worsening of steatosis and fibrosis progression Gut, September 1, 2003; 52(9): 1386 - 1387. [Full Text]
|
|
|
|
|
|
B. R. Shah and J. E. Hux Quantifying the Risk of Infectious Diseases for People With Diabetes Diabetes Care, February 1, 2003; 26(2): 510 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Greenberger Update in Gastroenterology Ann Intern Med, January 7, 2003; 138(1): 45 - 53. [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Bloomgarden Obesity, Hypertension, and Insulin Resistance Diabetes Care, November 1, 2002; 25(11): 2088 - 2097. [Full Text] [PDF]
|
|
|
|
|
|
O. Oncul, C. Top, and T. Cavuthlu Correlation of Serum Leptin Levels With Insulin Sensitivity in Patients With Chronic Hepatitis-C Infection Diabetes Care, May 1, 2002; 25(5): 937 - 937. [Full Text]
|
|
|
|
|
|
R. D. Bloom, V. Rao, F. Weng, R. A. Grossman, D. Cohen, and K. C. Mange Association of Hepatitis C with Posttransplant Diabetes in Renal Transplant Patients on Tacrolimus J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1374 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Bacon, A. M. Di Bisceglie, J. R. Korb, H. L. Tillmann, K. C. Herold, S. Himelhoch, R. J. de Knegt, A. P. van den Berg, B. P. Bell, B. D. Walker, et al. Hepatitis C Virus Infection N. Engl. J. Med., November 8, 2001; 345(19): 1425 - 1428. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mason Viral Induction of Type 2 Diabetes and Autoimmune Liver Disease J. Nutr., October 1, 2001; 131(10): 2805S - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Knobler and A. Schattner Association of Hepatitis C and Diabetes Mellitus Ann Intern Med, July 17, 2001; 135(2): 141 - 141. [Full Text] [PDF]
|
|
|
|
|
|
R. Paris Association of Hepatitis C and Diabetes Mellitus Ann Intern Med, July 17, 2001; 135(2): 141 - 142. [Full Text] [PDF]
|
|
|
|
|
|
G. J.M. Alexander An Association between Hepatitis C Virus Infection and Type 2 Diabetes Mellitus: What Is the Connection? Ann Intern Med, October 17, 2000; 133(8): 650 - 652. [Full Text] [PDF]
|
|
Article
